4.6 Review

Zinc as a complementary treatment for cancer patients: a systematic review

期刊

CLINICAL AND EXPERIMENTAL MEDICINE
卷 21, 期 2, 页码 297-313

出版社

SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10238-020-00677-6

关键词

Zinc; Cancer; Complementary medicine; Nutritional supplements; Immune system; Side effects

资金

  1. Projekt DEAL
  2. German Guideline S3 Leitlinie Komplementarmedizin in der Behandlung von onkologischen PatientInnen [032-055OL]
  3. German Cancer Aid within the German Guideline Programme in Oncology [11583]
  4. working group Prevention and Integrative Oncology of the German Cancer Society

向作者/读者索取更多资源

This study critically examined the role of zinc in cancer treatment, finding that zinc has a positive impact on mucositis after radiotherapy but not after chemotherapy. Zinc substitution may reduce taste loss, dry mouth, and oral pain, but does not significantly affect survival or quality of life. The risk of side effects from zinc is relatively small and it could be useful in preventing oral toxicities during irradiation.
Zinc is a trace element that plays an important role in the immune system and cell growth. The role of zinc in cancer treatment has been discussed for some time, however without reaching an evidenced-based consensus. Therefore, we aim to critically examine and review existing evidence on the role of zinc during cancer treatment. In January 2019, a systematic search was conducted searching five electronic databases (Embase, Cochrane, PsychINFO, CINAHL and PubMed) to find studies concerning the use, effectiveness and potential harm of zinc therapy on cancer patients. Out of initial 5244 search results, 19 publications concerning 23 studies with 1230 patients were included in this systematic review. The patients treated with zinc were mainly diagnosed with head and neck cancer and underwent chemo-, radio- or concurrent radio-chemotherapy. Interventions included the intake of different amounts of zinc supplements and oral zinc rinses. Outcomes (primary endpoints) investigated were mucositis, xerostomia, dysgeusia, pain, weight, dermatitis and oral intake of nutrients. Secondary endpoints were survival data, quality of life assessments and aspects of fatigue, immune responses and toxicities of zinc. The studies were of moderate quality reporting heterogeneous results. Studies have shown a positive impact on the mucositis after radiotherapy. No protection was seen against mucositis after chemotherapy. There was a trend to reduced loss of taste, less dry mouth and oral pain after zinc substitution. No impact was seen on weight, QoL measurements, fatigue, and survival. The risk of side effects from zinc appears to be relatively small. Zinc could be useful in the prevention of oral toxicities during irradiation. It does not help in chemotherapy-induced side effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据